Review Article
Efficacy and Safety of Rituximab in Vasculitic Neuropathy: A Systematic Review of the Literature
Eficacia y seguridad de rituximab en neuropatía vasculítica: revisión sistemática
Read
6477
Timeswas read the article
2357
Total PDF
4120
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 1 | 6 |
| 2025 5 | 172 | 61 | 233 |
| 2025 4 | 114 | 50 | 164 |
| 2025 3 | 120 | 42 | 162 |
| 2025 2 | 82 | 46 | 128 |
| 2025 1 | 75 | 54 | 129 |
| 2024 12 | 70 | 36 | 106 |
| 2024 11 | 69 | 65 | 134 |
| 2024 10 | 62 | 41 | 103 |
| 2024 9 | 65 | 28 | 93 |
| 2024 8 | 94 | 48 | 142 |
| 2024 7 | 93 | 45 | 138 |
| 2024 6 | 98 | 55 | 153 |
| 2024 5 | 87 | 35 | 122 |
| 2024 4 | 65 | 27 | 92 |
| 2024 3 | 70 | 34 | 104 |
| 2024 2 | 84 | 36 | 120 |
| 2024 1 | 61 | 22 | 83 |
| 2023 12 | 41 | 31 | 72 |
| 2023 11 | 69 | 40 | 109 |
| 2023 10 | 71 | 41 | 112 |
| 2023 9 | 113 | 56 | 169 |
| 2023 8 | 113 | 19 | 132 |
| 2023 7 | 40 | 23 | 63 |
| 2023 6 | 61 | 24 | 85 |
| 2023 5 | 59 | 27 | 86 |
| 2023 4 | 44 | 19 | 63 |
| 2023 3 | 66 | 24 | 90 |
| 2023 2 | 57 | 22 | 79 |
| 2023 1 | 47 | 21 | 68 |
| 2022 12 | 74 | 38 | 112 |
| 2022 11 | 69 | 30 | 99 |
| 2022 10 | 77 | 44 | 121 |
| 2022 9 | 65 | 53 | 118 |
| 2022 8 | 67 | 40 | 107 |
| 2022 7 | 47 | 36 | 83 |
| 2022 6 | 41 | 33 | 74 |
| 2022 5 | 48 | 35 | 83 |
| 2022 4 | 74 | 34 | 108 |
| 2022 3 | 86 | 62 | 148 |
| 2022 2 | 86 | 48 | 134 |
| 2022 1 | 77 | 42 | 119 |
| 2021 12 | 65 | 46 | 111 |
| 2021 11 | 47 | 50 | 97 |
| 2021 10 | 60 | 67 | 127 |
| 2021 9 | 55 | 41 | 96 |
| 2021 8 | 43 | 43 | 86 |
| 2021 7 | 44 | 39 | 83 |
| 2021 6 | 40 | 35 | 75 |
| 2021 5 | 50 | 43 | 93 |
| 2021 4 | 119 | 82 | 201 |
| 2021 3 | 73 | 47 | 120 |
| 2021 2 | 53 | 27 | 80 |
| 2021 1 | 51 | 33 | 84 |
| 2020 12 | 43 | 30 | 73 |
| 2020 11 | 49 | 24 | 73 |
| 2020 10 | 38 | 24 | 62 |
| 2020 9 | 36 | 28 | 64 |
| 2020 8 | 47 | 34 | 81 |
| 2020 7 | 36 | 32 | 68 |
| 2020 6 | 24 | 15 | 39 |
| 2020 5 | 32 | 25 | 57 |
| 2020 4 | 25 | 18 | 43 |
| 2020 3 | 12 | 6 | 18 |
Show all
